MassBio Maps Rescue Plan for Life Science Startups
The free-flowing funding climate in biotech slowed to a trickle in 2022, choking off the supply of tenants to fill Boston’s explosion of new life science real estate.
Most Popular | Most Recent
- Sluggish Permitting Blamed for Worsening Housing Crisis
- Community Good Works
- Zillow: Empty-Nest Homes Won’t Solve Boston Housing Issues
- Biz Groups Waver on Boston Tax Deal
- Law Firm Raises Profile with First South Station Tower Lease
- Top Fed Official Says December Rate Cut Depends on Data
- New Data Shows Boston Homeowners Face Smaller Tax Increase
- HarborOne Bank Partners With Wealth Management Platform
- The B&T Daily: Wednesday, Dec. 4
- Eastern Bank Slashes Suburban Office Footprint
- This Month in History: Failure of the Bank of New England 40 views
- Sluggish Permitting Blamed for Worsening Housing Crisis 23 views
- Tufts Partners with Capstone on School’s Biggest Dorm Project 17 views
- How Can Boston Build Nearly 3K New Public Housing Units? 14 views
- The $28B Merger That’s Not About Scale 13 views
- Zillow: Empty-Nest Homes Won’t Solve Boston Housing Issues 9 views
- Community Good Works 8 views
- Porter Square Parcels Eyed for Housing Development 8 views
- Merrimack Valley Credit Union and Cabot Boston Credit Union Merger Approved 7 views
- Law Firm Raises Profile with First South Station Tower Lease 7 views